Icon affirms FY26 guidance as Q2 adjusted EPS falls to $2.56

2 min read     Updated on 30 Jul 2026, 04:04 AM
scanx
Reviewed by
Suketu GScanX News Team
AI Summary

Icon plc reported Q2 2026 revenue of $2,063.5 million but saw adjusted EPS drop to $2.56 due to restructuring costs. Despite the quarterly miss, the company reaffirmed its full-year 2026 guidance for adjusted EPS ($10.00-$11.00) and revenue ($7.850B-$8.150B), which aligns closely with analyst estimates of $10.64 for EPS and $8.063B for sales.

powered bylight_fuzz_icon
46908718

*this image is generated using AI for illustrative purposes only.

Icon plc reaffirmed its full-year 2026 financial guidance on Tuesday, maintaining its adjusted diluted earnings per share (EPS) target of $10.00 to $11.00 and revenue outlook of $7.850 billion to $8.150 billion, despite a second-quarter earnings miss. The affirmation comes as analyst estimates for FY26 adjusted EPS stand at $10.64, placing the midpoint of Icon’s guidance slightly below consensus expectations, while sales estimates are pegged at $8.063 billion.

The company reported Q2 2026 revenue of $2,063.5 million, a 1.2% increase year-on-year and a 1.4% rise quarter-on-quarter. However, adjusted diluted EPS fell sharply to $2.56 from $3.52 in the same period last year, driven by restructuring charges and integration costs. GAAP net income for the quarter was $72.6 million, or $0.94 per diluted share. CEO Barry Balfe attributed the measured progress to strong strategic wins and new customer acquisition, which yielded a direct fee book-to-bill ratio of 1.2x.

Financial Performance

Revenue growth was primarily supported by higher pass-through activity, while direct fee performance remained resilient. Adjusted EBITDA for the quarter stood at $327.2 million, or 15.9% of revenue, representing a 21.7% decline year-on-year but a 3.0% increase sequentially. The effective tax rate on adjusted net income was 18.4%. Free cash flow reached $238.9 million, aided by operating cash generation of $281.3 million against capital expenditures of $42.4 million.

Metric Q2 2026 Q2 2025 Change
Revenue $2,063.5 million $2,039.1 million +1.2%
Adjusted EBITDA $327.2 million $417.8 million -21.7%
Adjusted EPS $2.56 $3.52 -27.3%
Net Business Wins $3,120 million $2,880 million +8.3%

Balance Sheet and Cash Flow

As of June 30, 2026, Icon held cash and cash equivalents of $928.4 million, compared to $765.2 million at March 31, 2026. Net debt stood at $2.5 billion, resulting in a net debt to adjusted EBITDA ratio of 1.8x. During the quarter, the company made $7.4 million in Term Loan B payments and recorded net cash outflows of $55.5 million related to the disposal of a subsidiary undertaking.

What the Numbers Show

The divergence between rising revenue and falling profitability highlights the impact of non-operational costs on Icon’s bottom line. While top-line growth accelerated with a book-to-bill ratio of 1.51, adjusted EBITDA margins compressed significantly year-on-year due to restructuring expenses of $20.9 million and transaction-related costs. However, the sequential improvement in adjusted EBITDA and the robust backlog suggest underlying operational stability despite these short-term headwinds. The reaffirmation of guidance indicates management’s confidence that these one-time costs will not materially impact the full-year trajectory.

How will the $20.9 million in restructuring charges and integration costs impact Icon's ability to meet the lower end of its $10.00-$11.00 EPS guidance range?

Given that analyst consensus EPS ($10.64) exceeds Icon's guidance midpoint, what specific operational efficiencies must the company demonstrate in Q3 and Q4 to avoid further downward revisions?

To what extent will the 1.2x direct fee book-to-bill ratio translate into accelerated revenue recognition in the second half of FY26, particularly amidst slowing year-over-year growth?

like15
dislike

ICON plc to announce Q2FY26 results on July 29

1 min read     Updated on 22 Jul 2026, 04:04 PM
scanx
Reviewed by
Jubin VScanX News Team
AI Summary

ICON plc announced it will release its Q2FY26 financial results after the market closes on July 29, 2026. A conference call to discuss performance is set for July 30, 2026, at 8:00am ET, with a webcast replay available shortly after.

powered bylight_fuzz_icon
46262050

*this image is generated using AI for illustrative purposes only.

ICON plc, a world-leading clinical research organization, will release its financial results for the second quarter of 2026 after the market closes on Wednesday, July 29, 2026. The company will hold a conference call and webcast to discuss its financial results and performance on Thursday, July 30, 2026, at 8:00am ET. The announcement provides investors with a specific timeline to assess the company's operational progress and financial health for the quarter.

Any changes to the event schedule and links to the live webcasts will be posted on the Investor section of the company's website under "Events". A webcast replay of the conference call will be available approximately one hour following the conclusion of the call, allowing stakeholders to access the discussion at their convenience.

Key Event Details

Event Date Time
Q2FY26 Results Release July 29, 2026 After market close
Conference Call & Webcast July 30, 2026 8:00am ET
Webcast Replay Availability July 30, 2026 ~1 hour post-call

Company Profile

ICON plc provides integrated consulting, clinical development, commercialization, and post-marketing solutions to pharmaceutical, biotechnology, medical device, government, and public health organizations worldwide. Headquartered in Dublin, Ireland, the company employed approximately 40,350 employees across 97 locations in 55 countries as of March 31, 2026.

What market trends in the pharmaceutical and biotechnology sectors could influence ICON's Q2 2026 performance?

How might ICON's global expansion and workforce size impact its operational efficiency and profitability in the coming quarters?

What strategic initiatives or partnerships is ICON pursuing to drive growth beyond Q2 2026?

like17
dislike

More News on Icon PLC